Fresenius Kabi USA is recalling approximately 25,057,650 vials of Sodium Chloride Injection, USP, 0.9%, because the product labels and inserts incorrectly state that the vial stoppers do not contain natural rubber latex. In reality, the stoppers for these specific batches do contain natural rubber latex, which was not disclosed to healthcare providers or patients. This voluntary recall affects 10 mL and 20 mL single-dose vials distributed nationwide across the United States and Puerto Rico.
Patients with a known sensitivity or allergy to natural rubber latex may experience a severe allergic reaction (anaphylaxis) if they are treated with these products. Because the labeling incorrectly claims the product is latex-free, healthcare providers may inadvertently use it on latex-sensitive patients, posing a critical risk of injury or death.
Contact healthcare provider and return for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.